Approved as monotherapy for pediatric epilepsy
Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves First in Class Therapy for Hereditary Angioedema
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
FDA Set Review Date for Imcivree for Rare Form of Obesity
Medicare Patients Face Higher Drug Costs Despite $2,000 Spending Cap
FDA Approves Tonmya for Adult Fibromyalgia
FDA Grants Accelerated Approval of Wegovy to Treat Liver Disease